 |
| Attached files |
| File | Filename |
| EX-32.01 - CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - CHINA PEDIATRIC PHARMACEUTICALS, INC. | exhibit_32-1.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R50.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R47.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R20.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R38.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R27.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R58.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R10.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R5.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R41.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R49.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R26.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R21.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R51.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R34.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R16.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R14.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R13.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R60.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R15.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R19.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R23.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R11.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R12.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R4.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R1.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R17.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R3.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R7.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R24.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R36.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R22.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R35.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R59.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R6.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R45.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R2.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R53.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R40.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R32.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R8.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R31.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R30.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R44.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R56.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R28.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R29.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R43.htm |
| EXCEL - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | Financial_Report.xls |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R9.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R52.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R37.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R42.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R25.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R57.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R33.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R46.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R55.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R48.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R54.htm |
| XML - IDEA: XBRL DOCUMENT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | R39.htm |
| EX-31.02 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - CHINA PEDIATRIC PHARMACEUTICALS, INC. | exhibit_31-2.htm |
| EX-31.01 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A), AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - CHINA PEDIATRIC PHARMACEUTICALS, INC. | exhibit_31-1.htm |
| 10-Q - SEPTEMBER 30, 2011 QUARTERLY REPORT - CHINA PEDIATRIC PHARMACEUTICALS, INC. | cpdu_2012sept30-10q.htm |
v2.4.0.6
|
Statutory Reserve
|
9 Months Ended |
|
Sep. 30, 2012
|
| Insurance [Abstract] |
|
| Statutory Reserve |
NOTE 11 - STATUTORY RESERVE
In accordance with the laws and regulations
of the PRC, a wholly-owned Foreign Invested Enterprises income, after the payment of the PRC income taxes, shall be allocated to
the statutory surplus reserves and statutory public welfare fund. Prior to January 1, 2006 the proportion of allocation
for reserve was 10 percent of the profit after tax to the surplus reserve fund and additional 5-10 percent to the public affair
fund. The public welfare fund reserve was limited to 50 percent of the registered capital. Effective January
1, 2006, there is now only one fund requirement. The reserve is 10 percent of income after tax, not to exceed 50 percent
of registered capital.
Statutory Reserve funds are restricted
for set off against losses, expansion of production and operation or increase in register capital of the respective company. Statutory
public welfare fund is restricted to the capital expenditures for the collective welfare of employees. These reserves
are not transferable to the Company in the form of cash dividends, loans or advances. These reserves are therefore not
available for distribution except in liquidation. As at September 30, 2012 and December 31, 2011, the Company had allocated
$810,540 to these non-distributable reserve funds. |
| X |
- Details
| Name: |
us-gaap_InsuranceAbstract |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
xbrli:stringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24790-158529
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 60
-Paragraph 60
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 94-5
-Paragraph 8, 9
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529
Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24746-158529
Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.23(c))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 55
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6588579&loc=d3e24938-158530
Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 55
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6588579&loc=d3e24959-158530
+ Details
| Name: |
us-gaap_StatutoryAccountingPracticesDisclosureTextBlock |
| Namespace Prefix: |
us-gaap_ |
| Data Type: |
nonnum:textBlockItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
This web site and associated pages are not associated with, endorsed by, or sponsored by CHINA PEDIATRIC PHARMACEUTICALS, INC. and has no official or unofficial affiliation with CHINA PEDIATRIC PHARMACEUTICALS, INC.
Based on public records. Inadvertent errors are possible. Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
|
|